Seaport’s IPO adventure, obesity pill battles, and Makary’s troubles
Stat News • 5/7/2026 – 5/8/2026
Summary
This week on "The Readout LOUD" podcast, the discussion includes Seaport Therapeutics’ successful IPO, ongoing battles related to obesity pills, and the FDA commissioner's troubles at the White House.
Advertisement
Lindy Score Breakdown (V4.2)
6d
Age
1
Sources
from cluster
137
Hours Since Seen
Final Score2/100
CategoryAntiLindy
StatusActive
Recency Multiplier14% (0.5^137/48)
Hero EligibleYes
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 6 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
The ‘velocity of obesity’ aims to show which nations are slowing an epidemic
Stat News • Today
Supreme Court temporarily extends women’s access to a widely used abortion pill
Stat News • 2 days ago
Medicare halts enrollment of new hospice, home health providers
Stat News • Today
New subpoena suggests DOJ has begun criminal investigation of gender-affirming care
Stat News • Today
Opinion: RFK Jr.’s antidepressant deprescribing push gets one thing right — and others dangerously wrong
Stat News • Today
STAT+: Drug meant to make gene therapy safer may also make it less effective
Stat News • Today
STAT+: Hims’ sales miss as telehealth competition grows
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about FDA’s Makary resigning, a Lilly weight loss drug trial, and more
Stat News • Today
STAT+: In the battle of sepsis algorithms, performance alone doesn’t predict victory
Stat News • 1 day ago
STAT+: Why Marty Makary was the worst FDA commissioner in 25 years
Stat News • 1 day ago
